Amgen believes that it can transcend the expected tradeoff between convenience and efficacy, anticipating that its ...

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

With Amgen, I don’t know if you remember, at the JPMorgan Healthcare Conference, I heard a lot of good things. The biotech really impressed me with a very strong pipeline.

Dow Jones biotech giant Amgen, along with fellow biotech stocks Gilead and Vertex, are due to report fourth-quarter earnings ...

The plant will help make Lilly's experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage trial.

CRISPR therapy STX-1150 could replace daily cholesterol pills with a single dose, reducing LDL by 50% for 18+ months using ...

A previous version of this story had an incorrect title for Brian Dunkin. He is the chief medical officer of endoscopy at Boston Scientific. The story has been corrected. Millions of Americans have ...

Lipoprotein(a) is a genetic cardiovascular risk factor affecting 20% of the global population, with no routine testing despite guideline recommendations. Current therapies offer modest Lp(a) reduction ...

Wegovy is now available as a daily oral pill with the same active ingredient as the injection. For some people, the pill may cause more intense side effects and slightly less weight loss than the ...

HARLINGEN, Texas (ValleyCentral) — You’ve probably seen the commercials on TV, or maybe you’ve seen the drastic before-and-after pictures on social media: Injectable weight loss drugs, or GLP-1s, have ...

President Donald Trump’s deals with pharmaceutical companies are likely to have only a limited impact on Americans’ drug spending, experts say. Since Sept. 30, the Trump administration has struck ...